Alerts
New BIOSECURE Act Targets Foreign-Linked Biotech
By Jianming Jimmy Hao, Ph.D., Joe Chen, Ph.D., Jonathan R. Lagarenne and Gerard P. Norton, Ph.D.
Publications
Articles
How to Navigate the Biosimilar and Biologic Markets Amid Challenging US Litigation Trends
Intellectual Asset Management
By Gerard P. Norton, Jonathan R. Lagarenne, Jianming Jimmy Hao, Howard S. Suh and Jonathan J. Madara
Articles
Biosimilars and Biologics Litigation in the United States
IAM
By Gerard P. Norton, Ph.D., Jonathan R. Lagarenne, Jianming Jimmy Hao, Ph.D., Howard S. Suh and Jonathan J. Madara
Alerts
Supreme Court Unanimously Affirms Enablement Requirement in Closely Watched Amgen-Sanofi Case
By Jonathan Madara*, Jianming Jimmy Hao, Peter F. Corless and Gerard P. Norton
Alerts
Government Contractors: Federally Funded Inventions Subject to New Disclosure Requirements and Deadlines
Intellectual Property Alert
By James M. Singer, Jianming Jimmy Hao, Ph.D. and Jeff E. Schwartz
